Symbol="IMCR"
AssetType="Common Stock"
Name="Immunocore Holdings Ltd"
Description="Immunocore Holdings Limited, an advanced stage biotechnology company, develops immunotherapies for the treatment of cancer, infectious and autoimmune diseases. The company is headquartered in Abingdon, the United Kingdom."
CIK="1671927"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="90 PARK DRIVE, MILTON PARK, ABINGDON, OXFORDSHIRE, GB"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="3040694000"
EBITDA="-36627000"
PERatio="None"
PEGRatio="None"
BookValue="5.67"
DividendPerShare="0"
DividendYield="0"
EPS="-1.15"
RevenuePerShareTTM="3.543"
ProfitMargin="-0.252"
OperatingMarginTTM="-0.244"
ReturnOnAssetsTTM="-0.0711"
ReturnOnEquityTTM="-0.191"
RevenueTTM="165804000"
GrossProfitTTM="54113000"
DilutedEPSTTM="-1.15"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.982"
AnalystTargetPrice="79.34"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="27.83"
PriceToBookRatio="8.13"
EVToRevenue="25.36"
EVToEBITDA="-54.19"
Beta="0.603"
num_52WeekHigh="69.06"
num_52WeekLow="38.9"
num_50DayMovingAverage="59.66"
num_200DayMovingAverage="57.5"
SharesOutstanding="46225200"
DividendDate="None"
ExDividendDate="None"
symbol="IMCR"
open="64.34"
high="67.04"
low="63.73"
price="65.78"
volume="202703.00"
latest_trading_day="2023-07-28"
previous_close="64.15"
change="1.63"
change_percent="2.5409%"
aroon_positive_momentum_days="54"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="54"
Volume_recent_avg="235126"
Change_recent_avg="0.15"
Delta_recent_avg="2.35"
Variance_recent_avg="1.18"
Change_ratio_recent_avg="0.21"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="54"
Aroon_momentum_negative="46"
image_negative_thumbnail_id_1="1134"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0167.jpeg"
image_negative_thumbnail_id_2="1156"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0190.jpeg"
image_neutral_thumbnail_id_1="596"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0003.jpeg"
image_neutral_thumbnail_id_2="558"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0041.jpeg"
image_positive_thumbnail_id_1="693"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0015.jpeg"
image_positive_thumbnail_id_2="650"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0058.jpeg"
image_professor_thumbnail_id_1="1197"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0031.jpeg"
image_professor_thumbnail_id_2="1171"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0005.jpeg"
